Klinická farmakologie a farmacie
Latest Publications

TOTAL DOCUMENTS

156

(FIVE YEARS 76)

H-INDEX

1

(FIVE YEARS 1)

Published By Solen S.R.O.

1212-7973, 1803-5353

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Nintedanib in treating interstitial lung disease associated with systemic scleroderma

Klinická farmakologie a farmacie ◽

10.36290/far.2021.022 ◽

2021 ◽

Vol 35 (3) ◽

pp. 80-86

Author(s):

Martina Šterclová

Keyword(s):

Interstitial Lung Disease ◽

Lung Disease ◽

Systemic Scleroderma

Download Full-text

Analysis of antibiotic consumption in the Czech Republic and its conclusions for clinical practice

Klinická farmakologie a farmacie ◽

10.36290/far.2021.017 ◽

2021 ◽

Vol 35 (3) ◽

pp. 49-55

Author(s):

Petr Domecký ◽

Lenka Suchopárová ◽

Josef Malý

Keyword(s):

Czech Republic ◽

Clinical Practice ◽

Antibiotic Consumption ◽

The Czech Republic

Download Full-text

Treatment of multiple myeloma in 2021

Klinická farmakologie a farmacie ◽

10.36290/far.2021.020 ◽

2021 ◽

Vol 35 (3) ◽

pp. 70-77

Author(s):

Jiří Minařík

Keyword(s):

Multiple Myeloma

Download Full-text

Hypertension chronotherapy: does dosing antihypertensive medication at bedtime determine cardiovascular prognosis?

Klinická farmakologie a farmacie ◽

10.36290/far.2021.012 ◽

2021 ◽

Vol 35 (2) ◽

pp. 74-77

Author(s):

Tomáš Baka ◽

Peter Stanko ◽

Fedor Šimko

Keyword(s):

Antihypertensive Medication ◽

Cardiovascular Prognosis

Download Full-text

Drug interactions of antiepileptic drugs Part 2: interaction with drugs of other indication groups

Klinická farmakologie a farmacie ◽

10.36290/far.2021.013 ◽

2021 ◽

Vol 35 (2) ◽

pp. 78-87

Author(s):

Blanka Kořístková ◽

Milan Grundmann

Keyword(s):

Drug Interactions ◽

Antiepileptic Drugs

Download Full-text

Oral manifestations of pharmacological treatment of systemic diseases

Klinická farmakologie a farmacie ◽

10.36290/far.2021.014 ◽

2021 ◽

Vol 35 (2) ◽

pp. 88-93

Author(s):

Beáta Bolerázska ◽

Anna Birková

Keyword(s):

Pharmacological Treatment ◽

Oral Manifestations ◽

Systemic Diseases

Download Full-text

Atherosclerotic cardiovascular diseases and clinical significance of treatment with inclisiran

Klinická farmakologie a farmacie ◽

10.36290/far.2021.011 ◽

2021 ◽

Vol 35 (2) ◽

pp. 69-73

Author(s):

Vladimír Blaha

Keyword(s):

Cardiovascular Diseases ◽

Clinical Significance ◽

Atherosclerotic Cardiovascular Diseases

Download Full-text

Dyskinesia induced by orphenadrine in fixed combination with diclofenac in two patients with advanced Parkinson's disease

Klinická farmakologie a farmacie ◽

10.36290/far.2021.016 ◽

2021 ◽

Vol 35 (2) ◽

pp. 99-100

Author(s):

Michal Minár ◽

Jana Švantnerová ◽

Simona Stanková ◽

Peter Matejička

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Fixed Combination ◽

Advanced Parkinson’S Disease

Download Full-text

The effect of valproic acid on plasma level of carbamazepine and carbamazepine-10, 11-epoxide in long-term treatment with slow-release drug formulations in pediatric patients: the importance of TDM

Klinická farmakologie a farmacie ◽

10.36290/far.2021.008 ◽

2021 ◽

Vol 35 (2) ◽

pp. 49-53

Author(s):

Blanka Kořístková ◽

Milan Grundmann ◽

Hana Brozmanová ◽

Ivana Kacířová

Keyword(s):

Valproic Acid ◽

Plasma Level ◽

Pediatric Patients ◽

Slow Release ◽

Term Treatment ◽

Drug Formulations ◽

Release Drug ◽

Long Term Treatment

Download Full-text

Metamizole (dipyrone)

Klinická farmakologie a farmacie ◽

10.36290/far.2021.015 ◽

2021 ◽

Vol 35 (2) ◽

pp. 94-98

Author(s):

Jitka Rychlíčková ◽

Hana Jurečková

Download Full-text